Cover Image
市場調查報告書

失眠症的全球市場:產業分析,規模,佔有率,成長,趨勢及預測(2017年∼2026年)

Insomnia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026

出版商 Transparency Market Research 商品編碼 606161
出版日期 內容資訊 英文 170 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
失眠症的全球市場:產業分析,規模,佔有率,成長,趨勢及預測(2017年∼2026年) Insomnia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026
出版日期: 2018年01月25日 內容資訊: 英文 170 Pages
簡介

據睡眠健康基金會報告,失眠估計影響全球三分之一的人口。失眠的特徵是基於多種模式,例如難以入睡和維持,通常伴隨著過早覺醒和再次睡著或經常醒來。長期失眠已經影響患有該疾病的人的日常生活,如果不及時治療,則會導致神經衰弱或嚴重抑鬱症。越來越多的專利分子和潛在的臨床輸液藥物在治療失眠症方面有希望。隨著老年人口成長,城市人口的壓力水平不斷上升,失眠治療的需求將出現大幅上升。

本報告提供全球失眠症市場相關調查分析,產業分析,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等系統性資訊。

目錄

第1章 全球經濟預測

第2章 摘要整理

第3章 市場概要

  • 簡介
    • 市場分類
    • 市場定義
  • 市場規模(百萬美元)及預測:2012年∼2026年
    • 與前一年同期比較成長率(YoY)
  • 市場動態
  • 供應鏈
  • 成本結構
  • 價格分析
  • 產品的生命週期
  • 大環境分析
  • 分銷商一覽

第4章 市場分析與預測:2012年∼2026年

  • 市場規模與預測:各治療類型
    • 苯重氮基鹽
    • 非苯重氮基鹽系
    • 抗憂鬱症藥
    • Orexin拮抗劑
    • 褪黑激素拮抗劑
    • 設備
    • 其他的治療類型
  • 市場規模與預測:各銷售管道
    • 醫院藥局
    • 零售藥局、藥物店
    • 線上藥局

第5章 北美

第6章 南美

第7章 歐洲

第8章 日本

第9章 亞太地區 (日本以外)

第10章 中東、非洲地區

第11章 市場佔有率,競爭情形,企業簡介

  • 企業佔有率分析
  • 競爭情形
  • 企業概要
    • Merck & Co Company
    • Sanofi
    • Pfizer Inc.
    • 武田藥品工業
    • Vanda Pharmaceuticals Inc.
    • Mylan NV
    • Teva Pharmaceutical Industries Limited
    • 大日本住友製藥
    • Paratek Pharmaceuticals, Inc.
    • Pernix Therapeutics Holdings, Inc.

第12章 調查方法

第13章 二次及一次來源

第14章 前提和縮寫

第15章 免責聲明

目錄

Title:
Insomnia Market (Treatment Type - Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Devices, and Other Treatment Types; Sales Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026.

According to the Sleep Health Foundation, Insomnia has been estimated to affect over one-third of the global population. Insomnia is characterized on the basis of multiple patterns such as difficulty in sleep initiation & maintenance that is usually accompanied with awakening too early & trouble sleeping again or frequent awakenings. Long-term insomnia has impacted daily life of individuals suffering from the disease, and has been associated with nervous breakdown or severe depression if left untreated. Increasing presence of patented molecules and potential clinical pipeline drug candidates hold promise in the treatment of insomnia. Demand for insomnia therapeutics will witness a tremendous rise on the back of growing geriatric population, and rising stress level among the urban population.

Transparency Market Research (TMR) has published a new insightful report on the global insomnia market. The report delivers forecasts on the global insomnia market, and examines the market in detail, providing important dynamics affecting the market expansion. Along with the provision of information on latest market trends, restraining factors, and augmenting factors impacting growth of the market, analysis on the data regarding multiple market parameters has been included in the report.

Report Structure

The report's initiates with a chapter titled "executive summary", which issues a summation of global insomnia market coupled with the information on imperative market numbers such as historical CAGR (2012-2016) and forecast CAGR (2017-2026). These numbers rendered are associated with the market segments incorporated in the report. Trailing the executive summary is a chapter titled "overview" that incorporates the definition of "insomnia", which succeeds an incisive market introduction. The overview chapter clearly describes the wide scope of global insomnia market. Some chapters in the report offer information on the pricing analysis coupled with the cost structure regarding the global insomnia market.

Competition Landscape

A scrupulous analysis regarding the global insomnia market's competition landscape has been issued in the concluding chapter of this report, incorporating information on prominent industries that significantly contribute to the market expansion. Occupancy of these market participants is tracked with the aid of an intensity map. Profiling key market participants rigorously, this chapter offers insights based on SWOT analysis, key developments, key financials, company overview, and product overview.

Research Methodology

A robust research methodology, proven & tested, has been employed by TMR's analysts to develop the report on global insomnia market. The research methodology used has helped analysts in offering accurate insights related to the global insomnia market. It depends entirely upon the secondary and primary researches, for gaining important information associated with the market. The information compiled has then been validated by the analysts several times for ensuring the report's authenticity, and for making it a reliable & authoritative source of reference for readers of the report.

Table of Contents

1. Global Economic Outlook

2. Global Insomnia Market - Executive Summary

3. Global Insomnia Market Overview

  • 3.1. Introduction
    • 3.1.1. Global Insomnia Market Taxonomy
    • 3.1.2. Global Insomnia Market Definition
  • 3.2. Global Insomnia Market Size (US$ Mn) and Forecast, 2012-2026
    • 3.2.1. Global Insomnia Market Y-o-Y Growth
  • 3.3. Global Insomnia Market Dynamics
  • 3.4. Supply Chain
  • 3.5. Cost Structure
  • 3.6. Pricing Analysis
  • 3.7. Product Life Cycle
  • 3.8. PESTLE Analysis
  • 3.9. List of Distributors

4. Global Insomnia Market Analysis and Forecast 2012-2026

  • 4.1. Global Insomnia Market Size and Forecast By Treatment Type, 2012-2026
    • 4.1.1. Benzodiazepines Market Size and Forecast, 2012-2026
      • 4.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.1.2. Market Share Comparison, By Region
      • 4.1.1.3. Y-o-Y growth Comparison, By Region
    • 4.1.2. Nonbenzodiazepines Market Size and Forecast, 2012-2026
      • 4.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.2.2. Market Share Comparison, By Region
      • 4.1.2.3. Y-o-Y growth Comparison, By Region
    • 4.1.3. Antidepressants Market Size and Forecast, 2012-2026
      • 4.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.3.2. Market Share Comparison, By Region
      • 4.1.3.3. Y-o-Y growth Comparison, By Region
    • 4.1.4. Orexin Antagonist Market Size and Forecast, 2012-2026
      • 4.1.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.4.2. Market Share Comparison, By Region
      • 4.1.4.3. Y-o-Y growth Comparison, By Region
    • 4.1.5. Melatonin Antagonist Market Size and Forecast, 2012-2026
      • 4.1.5.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.5.2. Market Share Comparison, By Region
      • 4.1.5.3. Y-o-Y growth Comparison, By Region
    • 4.1.6. Devices Market Size and Forecast, 2012-2026
      • 4.1.6.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.6.2. Market Share Comparison, By Region
      • 4.1.6.3. Y-o-Y growth Comparison, By Region
    • 4.1.7. Other Treatment Types Market Size and Forecast, 2012-2026
      • 4.1.7.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.7.2. Market Share Comparison, By Region
      • 4.1.7.3. Y-o-Y growth Comparison, By Region
  • 4.2. Global Insomnia Market Size and Forecast By Sales Channel, 2012-2026
    • 4.2.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
      • 4.2.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.1.2. Market Share Comparison, By Region
      • 4.2.1.3. Y-o-Y growth Comparison, By Region
    • 4.2.2. Retail Pharmacies and Drug Stores Market Size and Forecast, 2012-2026
      • 4.2.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.2.2. Market Share Comparison, By Region
      • 4.2.2.3. Y-o-Y growth Comparison, By Region
    • 4.2.3. Online Pharmacies Market Size and Forecast, 2012-2026
      • 4.2.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.3.2. Market Share Comparison, By Region
      • 4.2.3.3. Y-o-Y growth Comparison, By Region

5. North America Insomnia Market Size and Forecast, 2012-2026

  • 5.1. North America Outlook
  • 5.2. North America Parent Market Outlook
  • 5.3. North America Target Market Outlook
  • 5.4. Revenue (US$ Mn) Comparison, By Country
    • 5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
    • 5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
  • 5.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 5.6. Revenue (US$ Mn) Comparison, By Sales Channel

6. Latin America Insomnia Market Size and Forecast, 2012-2026

  • 6.1. Latin America Outlook
  • 6.2. Latin America Parent Market Outlook
  • 6.3. Latin America Target Market Outlook
  • 6.4. Revenue (US$ Mn) Comparison, By Country
    • 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
  • 6.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 6.6. Revenue (US$ Mn) Comparison, By Sales Channel

7. Europe Insomnia Market Size and Forecast, 2012-2026

  • 7.1. Europe Outlook
  • 7.2. Europe Parent Market Outlook
  • 7.3. Europe Target Market Outlook
  • 7.4. Revenue (US$ Mn) Comparison, By Country
    • 7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
  • 7.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 7.6. Revenue (US$ Mn) Comparison, By Sales Channel

8. Japan Insomnia Market Size and Forecast, 2012-2026

  • 8.1. Japan Outlook
  • 8.2. Japan Parent Market Outlook
  • 8.3. Japan Target Market Outlook
  • 8.4. Revenue (US$ Mn) Comparison, By Country
    • 8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
  • 8.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 8.6. Revenue (US$ Mn) Comparison, By Sales Channel

9. APEJ Insomnia Market Size and Forecast, 2012-2026

  • 9.1. APEJ Outlook
  • 9.2. APEJ Parent Market Outlook
  • 9.3. APEJ Target Market Outlook
  • 9.4. Revenue (US$ Mn) Comparison, By Country
    • 9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
  • 9.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 9.6. Revenue (US$ Mn) Comparison, By Sales Channel

10. MEA Insomnia Market Size and Forecast, 2012-2026

  • 10.1. MEA Outlook
  • 10.2. MEA Parent Market Outlook
  • 10.3. MEA Target Market Outlook
  • 10.4. Revenue (US$ Mn) Comparison, By Country
    • 10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
  • 10.5. Revenue (US$ Mn) Comparison, By Treatment Type
  • 10.6. Revenue (US$ Mn) Comparison, By Sales Channel

11. Global Insomnia Market Company Share, Competition Landscape and Company Profiles

  • 11.1. Company Share Analysis
  • 11.2. Competition Landscape
  • 11.3. Company Profiles
    • 11.3.1. Merck & Co Company
    • 11.3.2. Sanofi
    • 11.3.3. Pfizer Inc.
    • 11.3.4. Takeda Pharmaceutical Company Limited
    • 11.3.5. Vanda Pharmaceuticals Inc.
    • 11.3.6. Mylan N.V.
    • 11.3.7. Teva Pharmaceutical Industries Limited
    • 11.3.8. Sumitomo Dainippon Pharma Co., Ltd.
    • 11.3.9. Paratek Pharmaceuticals, Inc.
    • 11.3.10. Pernix Therapeutics Holdings, Inc.

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

List Of Table

  • TABLE 1 Global Insomnia Market Value (US$ Mn), 2012-2017
  • TABLE 2 Global Insomnia Market Value (US$ Mn), 2018-2026
  • TABLE 3 Global Insomnia Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • TABLE 4 Global Benzodiazepines Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 5 Global Benzodiazepines Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 6 Global Benzodiazepines Segment Market Share, By Region 2012-2017
  • TABLE 7 Global Benzodiazepines Segment Market Share, By Region 2018-2026
  • TABLE 8 Global Benzodiazepines Segment Y-o-Y, By Region 2017-2026
  • TABLE 9 Global Nonbenzodiazepines Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 10 Global Nonbenzodiazepines Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 11 Global Nonbenzodiazepines Segment Market Share, By Region 2012-2017
  • TABLE 12 Global Nonbenzodiazepines Segment Market Share, By Region 2018-2026
  • TABLE 13 Global Nonbenzodiazepines Segment Y-o-Y, By Region 2017-2026
  • TABLE 14 Global Antidepressants Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 15 Global Antidepressants Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 16 Global Antidepressants Segment Market Share, By Region 2012-2017
  • TABLE 17 Global Antidepressants Segment Market Share, By Region 2018-2026
  • TABLE 18 Global Antidepressants Segment Y-o-Y, By Region 2017-2026
  • TABLE 19 Global Orexin Antagonist Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 20 Global Orexin Antagonist Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 21 Global Orexin Antagonist Segment Market Share, By Region 2012-2017
  • TABLE 22 Global Orexin Antagonist Segment Market Share, By Region 2018-2026
  • TABLE 23 Global Orexin Antagonist Segment Y-o-Y, By Region 2017-2026
  • TABLE 24 Global Melatonin Antagonist Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 25 Global Melatonin Antagonist Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 26 Global Melatonin Antagonist Segment Market Share, By Region 2012-2017
  • TABLE 27 Global Melatonin Antagonist Segment Market Share, By Region 2018-2026
  • TABLE 28 Global Melatonin Antagonist Segment Y-o-Y, By Region 2017-2026
  • TABLE 29 Global Devices Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 30 Global Devices Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 31 Global Devices Segment Market Share, By Region 2012-2017
  • TABLE 32 Global Devices Segment Market Share, By Region 2018-2026
  • TABLE 33 Global Devices Segment Y-o-Y, By Region 2017-2026
  • TABLE 34 Global Other Treatment Types Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 35 Global Other Treatment Types Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 36 Global Other Treatment Types Segment Market Share, By Region 2012-2017
  • TABLE 37 Global Other Treatment Types Segment Market Share, By Region 2018-2026
  • TABLE 38 Global Other Treatment Types Segment Y-o-Y, By Region 2017-2026
  • TABLE 39 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 40 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 41 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 42 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 43 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 44 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 45 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 46 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2012-2017
  • TABLE 47 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2018-2026
  • TABLE 48 Global Retail Pharmacies and Drug Stores Segment Y-o-Y, By Region 2017-2026
  • TABLE 49 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 50 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 51 Global Online Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 52 Global Online Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 53 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 54 North America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 55 North America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 56 North America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 57 North America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 58 North America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 59 North America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 60 Latin America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 61 Latin America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 62 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 63 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 64 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 65 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 66 Europe Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 67 Europe Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 68 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 69 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 70 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 71 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 72 Japan Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 73 Japan Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 74 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 75 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 76 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 77 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 78 APEJ Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 79 APEJ Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 80 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 81 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 82 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 83 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • TABLE 84 MEA Insomnia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 85 MEA Insomnia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 86 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 87 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 88 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • TABLE 89 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026

List Of Figures

  • FIG. 1 Global Insomnia Market Value (US$ Mn), 2012-2017
  • FIG. 2 Global Insomnia Market Value (US$ Mn) Forecast, 2018-2026
  • FIG. 3 Global Insomnia Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • FIG. 4 Global Benzodiazepines Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 5 Global Benzodiazepines Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 6 Global Benzodiazepines Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 7 Global Nonbenzodiazepines Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 8 Global Nonbenzodiazepines Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 9 Global Nonbenzodiazepines Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 10 Global Antidepressants Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 11 Global Antidepressants Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 12 Global Antidepressants Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 13 Global Orexin Antagonist Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 14 Global Orexin Antagonist Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 15 Global Orexin Antagonist Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 16 Global Melatonin Antagonist Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 17 Global Melatonin Antagonist Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 18 Global Melatonin Antagonist Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 19 Global Devices Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 20 Global Devices Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 21 Global Devices Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 22 Global Other Treatment Types Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 23 Global Other Treatment Types Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 24 Global Other Treatment Types Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 25 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 26 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 27 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 28 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 29 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 30 Global Retail Pharmacies and Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 31 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 32 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 33 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 34 North America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 35 North America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 36 North America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 37 North America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 38 North America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 39 North America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 40 Latin America Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 41 Latin America Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 42 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 43 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 44 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 45 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 46 Europe Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 47 Europe Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 48 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 49 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 50 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 51 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 52 Japan Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 53 Japan Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 54 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 55 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 56 Japan Insomnia Market Value (US$ Mn), By 2012-2017
  • FIG. 57 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 58 APEJ Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 59 APEJ Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 60 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 61 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 62 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 63 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
  • FIG. 64 MEA Insomnia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 65 MEA Insomnia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 66 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 67 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 68 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
  • FIG. 69 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
Back to Top